SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : RNAi
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: Ian@SI6/21/2005 5:12:37 PM
   of 671
 
I don't recognize the name of either company mentioned in this from Briefing. ... or is that 3 companies? <G> [Bentice/Benitec and ARWR]

++++++++++++++++++++++++++++++++

Arrowhead Research (ARWR) subsidiary Calando Pharma grants exclusive worldwide license to Bentice (BLT) for the combination of Calando's polymeric nucleic acid delivery technology with Benitec's RNA interference (RNAi)-based therapeutic for hepatitis C virus...
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News